James E Flynn

NUVL

James E Flynn serves as director, 10 percent owner, other: * Director by Deputization at Nuvalent, Inc. (NUVL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

13 trades

$203.75M

Total Sells

8 trades

$159.66M

Net Position

Net Buyer

$44.09M

Companies Traded

LRMR, NUVL, SPRY, BCAX

Active Period

Mar 2021 – Mar 2026

21 total trades

Most Recent

Buy LRMR

Mar 2, 2026 · $25.00M

James E Flynn's Insider Trading at Nuvalent, Inc. (NUVL)

Buys

2 · $26.88M

Sells

2 · $133.19M

Total Shares Bought

950,000

Total Shares Sold

1,371,287

NUVL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 24, 2025	Sell	371,287	$95.45	$35.44M	0
Oct 24, 2024	Sell	1,000,000	$97.75	$97.75M	8,670,512
Nov 7, 2022	Buy	650,000	$33.50	$21.77M	650,000
Aug 4, 2021	Buy	300,000	$17.00	$5.10M	2,717,628

James E Flynn's Insider Trading at Larimar Therapeutics, Inc. (LRMR)

Buys

5 · $94.75M

Sells

0 · $0.00

Total Shares Bought

20,698,898

Total Shares Sold

LRMR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 2, 2026	Buy	5,000,000	$5.00	$25.00M	10,622,957
Jul 31, 2025	Buy	9,375,000	$3.20	$30.00M	0
Feb 16, 2024	Buy	2,860,411	$8.74	$25.00M	6,151,389
Sep 20, 2022	Buy	2,777,777	$3.15	$8.75M	4,721,183
Jul 2, 2021	Buy	685,710	$8.75	$6.00M	1,943,423

James E Flynn's Insider Trading at The Oncology Institute, Inc. Warrant (TOIIW)

Buys

1 · $50.00M

Sells

0 · $0.00

Total Shares Bought

50,000

Total Shares Sold

TOIIW Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 16, 2021	Buy	50,000	$1000.00	$50.00M	58,945

James E Flynn's Insider Trading at ARS Pharmaceuticals, Inc. (SPRY)

Buys

0 · $0.00

Sells

2 · $19.04M

Total Shares Bought

Total Shares Sold

1,039,191

SPRY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 27, 2025	Sell	740,149	$18.46	$13.66M	0
Nov 13, 2024	Sell	299,042	$17.98	$5.38M	5,498,368

James E Flynn's Insider Trading at Werewolf Therapeutics, Inc. (HOWL)

Buys

1 · $12.80M

Sells

0 · $0.00

Total Shares Bought

800,000

Total Shares Sold

HOWL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 4, 2021	Buy	800,000	$16.00	$12.80M	2,552,787

James E Flynn's Insider Trading at Edgewise Therapeutics, Inc. (EWTX)

Buys

1 · $10.00M

Sells

0 · $0.00

Total Shares Bought

625,000

Total Shares Sold

EWTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 30, 2021	Buy	625,000	$16.00	$10.00M	3,933,137

James E Flynn's Insider Trading at Xilio Therapeutics, Inc. (XLO)

Buys

1 · $6.20M

Sells

0 · $0.00

Total Shares Bought

387,500

Total Shares Sold

XLO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 28, 2021	Buy	387,500	$16.00	$6.20M	1,143,972

James E Flynn's Insider Trading at AdaptHealth Corp. (AHCO)

Buys

0 · $0.00

Sells

1 · $3.82M

Total Shares Bought

Total Shares Sold

350,000

AHCO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 8, 2024	Sell	350,000	$10.90	$3.82M	0

James E Flynn's Insider Trading at Mirum Pharmaceuticals, Inc. (MIRM)

Buys

0 · $0.00

Sells

3 · $3.62M

Total Shares Bought

Total Shares Sold

204,478

MIRM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 8, 2022	Sell	38,478	$25.01	$962.3K	1,711,324
Jul 13, 2021	Sell	99,325	$15.81	$1.57M	0
Jul 7, 2021	Sell	66,675	$16.29	$1.09M	155,401

James E Flynn's Insider Trading at PepGen Inc. (PEPG)

Buys

1 · $2.50M

Sells

0 · $0.00

Total Shares Bought

208,333

Total Shares Sold

PEPG Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 10, 2022	Buy	208,333	$12.00	$2.50M	476,813

James E Flynn's Insider Trading at Bicara Therapeutics Inc. Common Stock (BCAX)

Buys

1 · $630.0K

Sells

0 · $0.00

Total Shares Bought

35,000

Total Shares Sold

BCAX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 17, 2024	Buy	35,000	$18.00	$630.0K	0

Related Insiders

Henry E. Pelish

officer: Chief Scientific Officer

NUVLSell · Apr 13, 2026

James Richard Porter

President and CEO

NUVLSell · Apr 8, 2026

Darlene Noci

officer: Chief Development Officer

NUVLSell · Apr 1, 2026

Deborah Ann Miller

officer: Chief Legal Officer

NUVLSell · Mar 30, 2026

Alexandra Balcom

officer: Chief Financial Officer

NUVLSell · Mar 26, 2026

SHERMAN JEFFREY W

director

LRMRBuy · Mar 2, 2026

Thomas Edward Hamilton

director

LRMRBuy · Mar 2, 2026

THOMAS FRANK E

director

LRMRBuy · Mar 2, 2026

Explore More Insider Trading Data

NUVL Insider Trading Activity

View all insider trades at Nuvalent, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity